Evidence map›Paper›PMID 41263023›Full record

ArticleInfection control and hospital epidemiology2026

Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system.

Jared Olson, Adam Hersh, John Veillette, C Dustin Waters, Brandon J Webb, Nick Tinker, Stephanie May, Michelle Matheu, Nora Fino, Rachel Foster and 8 more

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jared OlsonDivision of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utahhttps://ror.org/03r0ha626, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-3281-9614
Adam HershDivision of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utahhttps://ror.org/03r0ha626, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-0148-046X
John VeilletteInfectious Diseases Telehealth Service, Intermountain Health, Murray, UT, USA.ORCID https://orcid.org/0000-0001-7662-7609
C Dustin WatersDepartment of Pharmacy, McKay-Dee Hospital, Ogden, UT, USA.ORCID https://orcid.org/0000-0003-4500-9810
Brandon J WebbDivision of Infectious Diseases, Intermountain Medical Center, Murray, UT, USA.ORCID https://orcid.org/0000-0002-1799-3315
Nick TinkerInfectious Diseases Telehealth Service, Intermountain Health, Murray, UT, USA.ORCID https://orcid.org/0000-0002-7573-432X
Stephanie MayInfectious Diseases Telehealth Service, Intermountain Health, Murray, UT, USA.
Michelle MatheuDivision of Infectious Diseases, Intermountain Medical Center, Murray, UT, USA.ORCID https://orcid.org/0009-0003-1757-457X
Nora FinoDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-6209-1740
Rachel FosterDepartment of Pharmacy, Intermountain Medical Center, Murray, UT, USA.
Mary HuttonDepartment of Pharmacy, Utah Valley Hospital, Provo, UT, USA.ORCID https://orcid.org/0000-0001-6397-7511
Erin StahlPharmacy Services, Intermountain Health, Taylorsville, UT, USA.
Jena RhodesDepartment of Pharmacy, Primary Children's Hospital, Salt Lake City, UT, USA.ORCID https://orcid.org/0009-0000-7961-9081
Edward StenehjemDepartment of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.ORCID https://orcid.org/0000-0001-6065-9964
Andrew PaviaDivision of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utahhttps://ror.org/03r0ha626, Salt Lake City, UT, USA.
Payal PatelDivision of Infectious Diseases, Intermountain Medical Center, Murray, UT, USA.ORCID https://orcid.org/0000-0001-8666-7313
Allan SeibertDivision of Infectious Diseases, Intermountain Medical Center, Murray, UT, USA.ORCID https://orcid.org/0000-0002-8142-3405
Whitney BuckelPharmacy Services, Intermountain Health, Taylorsville, UT, USA.ORCID https://orcid.org/0000-0001-9505-2572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShorter antibiotic courses and transition to oral therapy for uncomplicated gram-negative bloodstream infections (GN-BSI) are evidence-supported yet remain challenging to implement. Here we report our experience with a GN-BSI antimicrobial stewardship (AS) quality improvement initiative in a large health system.

methodsWe implemented two sequential AS interventions in adult patients hospitalized with uncomplicated GN-BSI: (1) mandatory AS review of patients discharging on intravenous (IV) antibiotics ("OPAT review") and (2) a clinical guideline informing oral antibiotic transition and duration, in our 22-hospital system. We evaluated the initiative from January 2018 to September 2024. Pre- and postimplementation rates of (1) IV antibiotics at discharge and (2) total length of antibiotic therapy were calculated across the following periods: preintervention, after OPAT review, and after guideline implementation. Secondary outcomes included duration <10 days, oral antibiotic prescribing, and guideline-recommended dosing.

results3,231 patients (preintervention: 666, postOPAT review: 1,357, postguideline: 1,208) were included. We observed decreases in IV antibiotics at discharge (22.7% preintervention, 10.7% postOPAT review, and 9.2% postguideline,

conclusionAfter implementing GN-BSI-focused AS initiatives in our large health system, we observed a shift toward more frequent oral rather than IV antibiotics at discharge, and shorter overall antibiotic durations, without obvious changes in adverse outcomes.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipBacteremiaGram-Negative Bacterial InfectionsAdministration, IntravenousAdministration, OralAdultAgedDuration of TherapyFemaleHumansMaleMiddle AgedPractice Guidelines as TopicQuality ImprovementAnti-Bacterial Agents

Identifiers

PMID41263023
PMCPMC12926339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.